Business Context and Reporting Period
Orchid Island Capital, Inc. (ORC), a Maryland corporation, filed this Form 8-K on March 4, 2021, reporting events occurring on March 2, 2021. The filing details the entry into a material definitive agreement regarding a public equity offering.
Key Financial Metrics and Transaction Details
- Equity Offering: The Company entered into an underwriting agreement with J.P. Morgan Securities LLC to sell 8,000,000 shares of Common Stock at $5.45 per share.
- Option Exercise: The underwriter exercised a 30-day option to purchase an additional 1,200,000 shares on March 3, 2021, bringing the total offering size to 9,200,000 shares.
- Net Proceeds: The Company estimates net proceeds of approximately $50.0 million after deducting estimated offering expenses.
- Closing Date: The transaction was expected to close on March 5, 2021.
Material Changes and Use of Proceeds
This filing represents a significant capital raise event. The Company intends to use the net proceeds to invest in a targeted mix of Agency Residential Mortgage-Backed Securities (RMBS) and for general corporate purposes. Subsequently, the Company plans to borrow against the acquired Agency RMBS through repurchase agreements to acquire additional Agency RMBS.
Outlook, Risks, and Contingencies
The closing of the offering is subject to the satisfaction of customary closing conditions. The Underwriting Agreement includes customary representations, warranties, and covenants. The Company has agreed to indemnify the Underwriter against certain liabilities under the Securities Act of 1933. The filing notes that the Underwriter or its affiliates may engage in various banking and advisory services with the Company in the ordinary course of business.
Investor Verification Checklist
- Verify the actual closing date and final net proceeds received, as the filing states an expectation of closing on March 5, 2021.
- Confirm the final number of shares issued if the underwriter's option was partially or fully exercised (filing indicates full exercise).
- Review the attached Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification terms.
- Monitor future filings for the deployment of proceeds into Agency RMBS and the associated leverage via repurchase agreements.